The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enters Offshore Arena with Global Energy Major

11 Oct 2010 07:00

RNS Number : 1413U
ViaLogy PLC
11 October 2010
 



 

ViaLogy Plc ("ViaLogy")

ViaLogy Enters Offshore Arena with Global Energy Major

Aims to demonstrate major improvements over conventional seismic analysis in deepwater and onshore

London, October 11, 2010. ViaLogy PLC (VIY) announces it has been engaged by a second global energy company for QuantumRD performance assessment projects. The analysis targets large oilfields outside the United States. Following the recent announcement of a supermajor contract, ViaLogy has been approached by several US and non-US companies for de-risking both onshore and offshore prospects.

Under the performance assessments, ViaLogy will use its proprietary quantum seismic interferometry technology, QuantumRD, to delineate productive formations in a deepwater reservoir for a large offshore development prospect. De-risking such prospects typically relies on drilling multiple, costly test wells because of the inability of conventional 3-D seismic analysis to image fluids. The offshore project requires that ViaLogy predict oil and/or gas bearing zones from 3D seismic data in a complex sandstone reservoir setting. Sandstone reservoirs are common across the globe and can be highly productive, depending upon the accuracy of mapping interlaced sediment within reservoir or basin-scale geometry to delineate source, seal and reservoir geologies. The value-add of QuantumRD is its ability to increase resolution of the seismic data to assess hydrocarbon presence and fluid saturation. The business value of being able to map subsurface saturation patterns is the potential to maximize extraction and production, and to avoid costs normally associated with locating hydrocarbons.

The client commissioning the work is a Fortune Global 500 company.

QuantumRD will also be used to determine the attributes of a major onshore formation for the client. The onshore application leverages QuantumRD's demonstrated ability to discover subtle channel sands in complex stratigraphies. ViaLogy intends to delineate and size production grade hydrocarbon-bearing depositions in an onshore reservoir that spans several hundred square miles.

These prospects have been previously analyzed by the some of the leading geophysical services providers. Both the client and the locations of the projects remain confidential.

ViaLogy has positioned QuantumRD to provide services on a global basis for a broad class of sandstone, carbonate and shale gas reservoirs to characterize formation porosity, lithology and map hydrocarbon presence. This follows two years of development and testing in onshore US prospects where QuantumRD successfully positioned multiple wells and, retrospectively, correctly explained the outcome of over 250 more wells.

ViaLogy CEO Robert W. Dean said, "These technology assessment projects are a major step forward for us, providing the opportunity to work in very large fields, showing the technology's capability offshore, and demonstrating its enormous commercial potential. In both of these offshore and onshore prospects currently available conventional seismic analysis technologies have thus far been unsuccessful."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMMMGDGFGGZM
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.